Literature DB >> 27382153

Lasso adjustments of treatment effect estimates in randomized experiments.

Adam Bloniarz1, Hanzhong Liu1, Cun-Hui Zhang2, Jasjeet S Sekhon3, Bin Yu4.   

Abstract

We provide a principled way for investigators to analyze randomized experiments when the number of covariates is large. Investigators often use linear multivariate regression to analyze randomized experiments instead of simply reporting the difference of means between treatment and control groups. Their aim is to reduce the variance of the estimated treatment effect by adjusting for covariates. If there are a large number of covariates relative to the number of observations, regression may perform poorly because of overfitting. In such cases, the least absolute shrinkage and selection operator (Lasso) may be helpful. We study the resulting Lasso-based treatment effect estimator under the Neyman-Rubin model of randomized experiments. We present theoretical conditions that guarantee that the estimator is more efficient than the simple difference-of-means estimator, and we provide a conservative estimator of the asymptotic variance, which can yield tighter confidence intervals than the difference-of-means estimator. Simulation and data examples show that Lasso-based adjustment can be advantageous even when the number of covariates is less than the number of observations. Specifically, a variant using Lasso for selection and ordinary least squares (OLS) for estimation performs particularly well, and it chooses a smoothing parameter based on combined performance of Lasso and OLS.

Keywords:  Lasso; Neyman–Rubin model; average treatment effect; high-dimensional statistics; randomized experiment

Mesh:

Year:  2016        PMID: 27382153      PMCID: PMC4941428          DOI: 10.1073/pnas.1510506113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  6 in total

1.  The pulmonary artery catheter-friend, foe, or accomplice?

Authors:  J E Dalen
Journal:  JAMA       Date:  2001-07-18       Impact factor: 56.272

2.  Testing for imbalance of covariates in controlled experiments.

Authors:  T Permutt
Journal:  Stat Med       Date:  1990-12       Impact factor: 2.373

3.  Optimal Tests of Treatment Effects for the Overall Population and Two Subpopulations in Randomized Trials, using Sparse Linear Programming.

Authors:  Michael Rosenblum; Han Liu; En-Hsu Yen
Journal:  J Am Stat Assoc       Date:  2014-01-01       Impact factor: 5.033

4.  Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomised controlled trial.

Authors:  Sheila Harvey; David A Harrison; Mervyn Singer; Joanne Ashcroft; Carys M Jones; Diana Elbourne; William Brampton; Dewi Williams; Duncan Young; Kathryn Rowan
Journal:  Lancet       Date:  2005 Aug 6-12       Impact factor: 79.321

5.  Higher Order Inference On A Treatment Effect Under Low Regularity Conditions.

Authors:  Lingling Li; Eric Tchetgen Tchetgen; Aad van der Vaart; James M Robins
Journal:  Stat Probab Lett       Date:  2011-07-01       Impact factor: 0.870

6.  The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators.

Authors:  A F Connors; T Speroff; N V Dawson; C Thomas; F E Harrell; D Wagner; N Desbiens; L Goldman; A W Wu; R M Califf; W J Fulkerson; H Vidaillet; S Broste; P Bellamy; J Lynn; W A Knaus
Journal:  JAMA       Date:  1996-09-18       Impact factor: 56.272

  6 in total
  13 in total

1.  Causal inference in randomized clinical trials.

Authors:  Cheng Zheng; Ran Dai; Robert Peter Gale; Mei-Jie Zhang
Journal:  Bone Marrow Transplant       Date:  2019-03-26       Impact factor: 5.483

2.  High-dimensional regression adjustments in randomized experiments.

Authors:  Stefan Wager; Wenfei Du; Jonathan Taylor; Robert J Tibshirani
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-25       Impact factor: 11.205

3.  Improving massive experiments with threshold blocking.

Authors:  Michael J Higgins; Fredrik Sävje; Jasjeet S Sekhon
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-05       Impact factor: 11.205

4.  Drawing causal inference from Big Data.

Authors:  Richard M Shiffrin
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-05       Impact factor: 11.205

5.  Time and skeptical opinion content erode the effects of science coverage on climate beliefs and attitudes.

Authors:  Brendan Nyhan; Ethan Porter; Thomas J Wood
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-21       Impact factor: 12.779

6.  Identification of an Inflammatory Response-Related Gene Signature to Predict Survival and Immune Status in Glioma Patients.

Authors:  Zhaoyue Yan; Yushuai Gao; Jinliang Yu; Zhiyuan Shen; Xingyao Bu
Journal:  J Immunol Res       Date:  2022-05-18       Impact factor: 4.493

7.  Low immune index correlates with favorable prognosis but with reduced benefit from chemotherapy in gallbladder cancer.

Authors:  Jie Wang; Xiaobo Bo; Changcheng Wang; Yanlei Xin; Lingxi Nan; Rongkui Luo; Lingli Chen; Xiao Shi; Tao Suo; Xiaoling Ni; Han Liu; Sheng Shen; Min Li; Pinxiang Lu; Yueqi Wang; Houbao Liu
Journal:  Cancer Sci       Date:  2019-12-12       Impact factor: 6.716

8.  Improving precision and power in randomized trials for COVID-19 treatments using covariate adjustment, for binary, ordinal, and time-to-event outcomes.

Authors:  David Benkeser; Iván Díaz; Alex Luedtke; Jodi Segal; Daniel Scharfstein; Michael Rosenblum
Journal:  Biometrics       Date:  2020-10-11       Impact factor: 1.701

9.  Estimating the Individual Treatment Effect on Survival Time Based on Prior Knowledge and Counterfactual Prediction.

Authors:  Yijie Zhao; Hao Zhou; Jin Gu; Hao Ye
Journal:  Entropy (Basel)       Date:  2022-07-14       Impact factor: 2.738

10.  Moving beyond the conventional stratified analysis to estimate an overall treatment efficacy with the data from a comparative randomized clinical study.

Authors:  L Tian; F Jiang; T Hasegawa; H Uno; M Pfeffer; L J Wei
Journal:  Stat Med       Date:  2018-10-23       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.